These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37874345)

  • 1. Psychedelic use and psychiatric risks.
    Simonsson O; Goldberg SB; Chambers R; Osika W; Simonsson C; Hendricks PS
    Psychopharmacology (Berl); 2023 Oct; ():. PubMed ID: 37874345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.
    Simonsson O; Hendricks PS; Stenfors CU; Goldberg SB; Honk L; Osika W
    J Psychopharmacol; 2024 Jan; 38(1):110-115. PubMed ID: 38140891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescent Psychedelic Use and Psychotic or Manic Symptoms.
    Simonsson O; Mosing MA; Osika W; Ullén F; Larsson H; Lu Y; Wesseldijk LW
    JAMA Psychiatry; 2024 Jun; 81(6):579-585. PubMed ID: 38477889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom.
    Honk L; Stenfors CUD; Goldberg SB; Hendricks PS; Osika W; Dourron HM; Lebedev A; Petrovic P; Simonsson O
    J Affect Disord; 2024 Apr; 351():194-201. PubMed ID: 38280572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and epidemiological associates of novel psychedelic use in the United States adult population.
    Sexton JD; Crawford MS; Sweat NW; Varley A; Green EE; Hendricks PS
    J Psychopharmacol; 2019 Sep; 33(9):1058-1067. PubMed ID: 30816808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.
    Simonsson O; Hendricks PS; Chambers R; Osika W; Goldberg SB
    J Affect Disord; 2023 Apr; 326():105-110. PubMed ID: 36720405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and associations of classic psychedelic-related seizures in a population-based sample.
    Simonsson O; Goldberg SB; Chambers R; Osika W; Long DM; Hendricks PS
    Drug Alcohol Depend; 2022 Oct; 239():109586. PubMed ID: 35981469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic psychedelics, health behavior, and physical health.
    Simonsson O; Hendricks PS; Chambers R; Osika W; Goldberg SB
    Ther Adv Psychopharmacol; 2022; 12():20451253221135363. PubMed ID: 36465958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom.
    Simonsson O; Osika W; Stenfors CUD; Goldberg SB; Honk L; Hendricks PS
    Psychol Med; 2024 Apr; 54(6):1228-1234. PubMed ID: 37859627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
    Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case analysis of long-term negative psychological responses to psychedelics.
    Bremler R; Katati N; Shergill P; Erritzoe D; Carhart-Harris RL
    Sci Rep; 2023 Sep; 13(1):15998. PubMed ID: 37749109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between lifetime classic psychedelic use and markers of physical health.
    Simonsson O; Sexton JD; Hendricks PS
    J Psychopharmacol; 2021 Apr; 35(4):447-452. PubMed ID: 33719688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development.
    Simonsson O; Stenfors CUD; Goldberg SB; Hendricks PS; Osika W
    Front Psychol; 2023; 14():1151626. PubMed ID: 37476092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classic Psychedelics and Human-Animal Relations.
    Pöllänen E; Osika W; Stenfors CUD; Simonsson O
    Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychedelics and mental health: a population study.
    Krebs TS; Johansen PØ
    PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classic psychedelic use and current meditation practice.
    Simonsson C; Chambers R; Hendricks PS; Goldberg SB; Osika W; Schlosser M; Ryde A; Christersson E; Simonsson O
    Mindfulness (N Y); 2023 Apr; 14(4):763-768. PubMed ID: 37693239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.
    Garcia-Romeu A; Davis AK; Erowid E; Erowid F; Griffiths RR; Johnson MW
    Front Psychiatry; 2019; 10():955. PubMed ID: 32038317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bodily self from psychosis to psychedelics.
    Harduf A; Panishev G; Harel EV; Stern Y; Salomon R
    Sci Rep; 2023 Dec; 13(1):21209. PubMed ID: 38040825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychedelic drug use and schizotypy in young adults.
    Lebedev AV; Acar K; Garzón B; Almeida R; Råback J; Åberg A; Martinsson S; Olsson A; Louzolo A; Pärnamets P; Lövden M; Atlas L; Ingvar M; Petrovic P
    Sci Rep; 2021 Jul; 11(1):15058. PubMed ID: 34301969
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.